Heller et al Biotechnol. Prog. 1997, 13, 590-596.* |
Edwards et al. Science. 1997;276:1868-1871.* |
Arakawa and Timasheff, “Preferential interactions of proteins with solvent components in aqueous amino acid solutions” Archives of Biochemistry & Biophysics 224(1):169-177 (Jul. 1, 1983). |
Arakawa and Timasheff, “Stabilization of protein structure by sugars” Biochemistry 21(25):6536-6544 (Dec. 7, 1982). |
Broadhead et al., “The effect of process and formulation variables on the properties of spray-dried β-galactosidase” Journal of Pharmacy & Pharmacology 46(6):458-467 (Jun. 1994). |
Carpenter et al., “Modes of Stabilization of a Protein by Organic Solutes during Desiccation” Cryobiology 25:459-470 (1988). |
Carpenter et al., “Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies” Archives of Biochemistry & Biophysics 303(2):456-464 (Jun. 1993). |
Carpenter et al., “The Mechanism of Cryoprotection of Proteins by Solutes” Cryobiology 25:244-255 (1988). |
Chan et al., “Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery” Pharmaceutical Research 14(4):431-437 (Apr. 1997). |
Chang et al., “Surface-induced denaturation of proteins during freezing and its inhibition by surfactants” Journal of Pharmaceutical Sciences 85(12):1325-1330 (Dec. 1996). |
Chilson et al., “Effects of freezing on enzymes” Federation Proceedings 24(2):S55-S65 (1965). |
Costantino et al., “Aggregation of a lyophilized pharmaceutical protein, recombinant human albumin: effect of moisture and stabilization by excipients” Bio/Technology 13(5):493-496 (May 1995). |
Crowe et al., “Are Freezing and Dehydration Similar Vectors? A Comparison of Modes of Interaction of Stabilizing Solutes with Biomolecules” Cryobiology 27:219-231 (1990). |
Eckhardt et al., “Effect of freezing on aggregation of human growth hormone” Pharmaceutical Research 8(11):1360-1364 (Nov. 1991). |
Edwards et al., “Large porous particles for pulmonary drug delivery” Science 276(5320):1868-1871 (Jun. 20, 1997). |
Hsu et al., “Surface denaturation at solid-void interface—a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures” Pharmaceutical Research 12(1):69-77 (Jan. 1995). |
Izutsu et al., “Decreased protein-stabilizing effects of cryoprotectants due to crystallization” Pharmaceutical Research 10(8):1232-1237 (Aug. 1993). |
Izutsu et al., “Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying” Chemical & Pharmaceutical Bulletin 42(1):5-8 (Jan. 1994). |
Izutsu et al., “Stabilization of β-galactosidase by amphiphilic additives during freeze-drying” International Journal of Pharmaceutics 90:187-194 (1993). |
Izutsu et al., “The effects of additives on the stability of freeze-dried β-galactosidase stored at elevated temperature” Intl. J. Pharmaceutics 71:137-146 (1991). |
Maa et al., “Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders” Pharmaceutical Research 15(5):768-775 (May 1998). |
Maa et al., “Protein Denaturation by Combined Effect of Shear and Air-Liquid Interface” Biotechnology and Bioengineering 54(6):503-512 (Jun. 20, 1997). |
Maa et al., “Spray-drying of air-liquid interface sensitive recombinant human growth hormone” Journal of Pharmaceutical Sciences 87(2):152-159 (Feb. 1998). |
Miki et al., “Difference in inhaled aerosol deposition patterns in the lungs due to three different sized aerosols” Nuclear Medicine Communications 13(7):553-562 (Jul. 1992). |
Mitchell et al., “Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma” Thorax 42(6):457-461 (Jun. 1987). |
Mumenthaler et al., “Feasibility Study on Spray-Drying Protein Pharmaceuticals: Recombinant Human Growth Hormone and Tissue-Type Plasminogen Activator” Pharm. Res. 11:12-20 (1994). |
Nema and Avis, “Freeze-thaw studies of a model protein, lactate dehydrogenase, in the presence of cryoprotectants” Journal of Parenteral Science & Technology 47(2):76-83 (Mar.-Apr. 1993). |
Prestrelski et al., “Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. II. Structural studies using infrared spectroscopy” Archives of Biochemistry & Biophysics 303(2):465-473 (Jun. 1993). |
Shikama et al., “Denaturation of Catalase by Freezing and Thawing” Nature 190(4770):83-84 (Apr. 1, 1961). |
Strambini and Gabellieri, “Proteins in frozen solutions: evidence of ice-induced partial unfolding” Biophysical Journal 70(2):917-976 (Feb. 1996). |
Tamiya et al., “Freeze denaturation of enzymes and its prevention with additives” Cryobiology 22(5):446-456 (Oct. 1985). |
Townsend and DeLuca, “Use of lyoprotectants in the freeze-drying of a model protein, ribonuclease A” Journal of Parenteral Science & Technology 42(6):190-199 (Nov.-Dec. 1988). |
Watanabe et al., “Protective Effects of Non-ionic Surfactants against Denaturation of Rabbit Skeletal Myosin by Freezing and Thawing” Agricultural and Biological Chemistry 52(10):2517-2523 (1988). |
Winters et al., “Precipitation of proteins in supercritical carbon dioxide” Journal of Pharmaceutical Sciences 85(6):586-594 (Jun. 1996). |
Yeo et al., “Formation of Microparticulate Protein Powders Using a Supercritical Fluid Antisolvent” Biotechnology and Bioengineering 41:341-346 (1993). |